Business Context and Reporting Period
This Form 8-K is filed by CareDx, Inc. (CDNA) on October 7, 2024, reporting on legal developments regarding prior investigations. The Company is a Delaware corporation headquartered in Brisbane, California.
Key Financial Metrics
This filing is a Current Report regarding legal events (Item 8.01 Other Events) and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
The primary material change reported is the closure of a Department of Justice (DOJ) investigation. Specifically:
- DOJ Investigation: The DOJ notified the United States District Court for the Eastern District of New York that it is declining to intervene in a qui tam action filed by a former employee. This action was the basis for a 2021 Civil Investigative Demand (CID) regarding False Claims Act allegations related to kidney testing and phlebotomy services. CareDx understands the DOJ has closed its investigation.
- SEC Investigation: Reiteration of a September 19, 2023, notification that the SEC concluded its investigation into similar matters and accounting practices and does not intend to recommend an enforcement action.
Outlook, Risks, and Management Commentary
While the DOJ has declined to intervene, the private qui tam action remains active. Management states that the Company denies the allegations in the qui tam action and intends to vigorously defend itself should the private plaintiff pursue these claims. The filing confirms the resolution of the regulatory investigations but highlights the ongoing litigation risk from the private plaintiff.
Key Facts for Investor Verification
- DOJ has declined to intervene in the qui tam lawsuit, effectively closing the government's investigation.
- The private plaintiff (former employee) may still pursue the lawsuit independently.
- The SEC investigation concluded in September 2023 with no enforcement action recommended.
- The Company denies all allegations and plans to defend against the private suit.